Wednesday, September 16, 2009

Denise Milani akiba-online

DALTON CEUTA: PRECAUTIONS IN CATARACT SURGERY IN PATIENTS with tamsulosin

www.qxeyes.com













A retrospective study published in the Journal of the American Medical Association shows the association between the use of tamsulosin , a drug commonly used in the treatment of benign prostatic hypertrophy , and the presence of serious complications during and extraoperatorias during cataract surgery.
X
The study shows that patients who receive or have received recent treatment with tamsulosin in the 14 days prior to surgery have a significantly higher incidence of complications in surgery cataract, increased incidence that it has been observed with other alpha-blockers used in the treatment of benign prostatic hypertrophy (BPH) .
X
Tamsulosin is a drug blocking alpha-adrenergic receptor that is frequently prescribed for the treatment of prostatic hypertrophy. Given its frequent use, patients should be warned of the perioperative risks and the ophthalmologist must be prepared for possible complications, since the suspension of treatment before surgery so does not reduce the risk of complications such as intraoperative floppy iris syndrome (IFIS).
x
To reduce potential intraoperative complications (IFIS, capsular rupture, vitreous loss, retinal detachment, ..) have proposed pharmacologic strategies and instruments such as the use of cycloplegic powerful (atropine, homatropine), denser viscoelastic under fluid flow, iris retractors, pupil dilator rings and expanders.
x
Both the patient and the ophthalmologist should be aware, be advisable for the surgeon to warn the patient before surgery if you are undergoing treatment with Tamsulosin for prostatic hypertrophy (Omnic, Omnic Geese, Urolosin, Urolosin geese) .
x
JAMA. 2009; 301:1991-1996, 2044-2045.
x
Basic Information and indicative. For personalized information consult your ophthalmologist.
x
CEUTA EYES. INNOVATION IN OPHTHALMOLOGY.
EYE CENTER DR. CATOIRA MEDIN

Eyes

0 comments:

Post a Comment